Emerging Vaccine Immunotherapy In NSCLC: The Adverse Reactions of Recent Clinical Trials and Future Directions | | |
PD-1/PD-L1 inhibitors in treatment-naïve, advanced non-small cell lung cancer patients with < 1% PD-L1 expression: a meta-analysis of randomized controlled trials | | |
The role of immunotherapy plus chemotherapy versus chemotherapy alone as first-line treatment for advanced non-small cell lung cancer: an updated systematic review and meta-analysis of randomized controlled trials | | |
The Blood Proteome of Imminent Lung Cancer Diagnosis | | |
Sputum analysis by flow cytometry; an effective platform to analyze the lung environment | | 2022 |
Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse Events | | 2022 |
TRAIL-induces Src mediated MEK/ERK, SMAD3 and β-catenin signalling in apoptosis resistant NSCLC cells | | |
Emerging Approaches to Complement Low-Dose Computerized Tomography for Lung Cancer Screening: A Narrative Review | | 2022 |
Evaluation of Lung Cancer Incidence Dynamics in Kyrgyzstan | | 2022 |
Current challenges of unresectable stage III NSCLC: are we ready to break the glass ceiling of the PACIFIC trial? | | 2022 |
Management of screen-detected lung nodule: A single-center experience | Formosan Journal of Surgery | 2022 |
Air pollution and lung cancer survival in Pennsylvania | Lung Cancer | 2022 |
Role of low dose computed tomography on lung cancer detection and mortality - an updated systematic review and meta-analysis | Monaldi Archives for Chest Disease | |
Efficacy comparison of immune treating strategies for NSCLC patients with negative PD-L1 expression | Expert Review of Clinical Immunology | |
Experimental approach to obtaining subcutaneous xenograft of non-small cell lung cancer | Issledovaniâ I Praktika V Medicine | 2022 |
Study of biological activity of 2-quinoline-2-yl-derivative 1,3-tropolone in experiment | Issledovaniâ I Praktika V Medicine | 2022 |
18F-FDG PET/CT for Response Assessment in Lung Cancer | Seminars in Nuclear Medicine | 2022 |
De- "bug"-ing the microbiome in lung cancer. | Cancer and Metastasis Reviews | 2022 |
The state of the art for artificial intelligence in lung digital pathology. | Journal of Pathology | 2022 |
A five-step strategy for building an LDCT lung cancer screening program | | |
Experimental investigation of microwave holographic reflectometry for lung tumor detection | Measurement: Journal of the International Measurement Confederation | 2022 |
Hypothesized Explanations for the Observed Lung Cancer Survival Benefit Among Hispanics/Latinos in the United States. | Journal of Racial and Ethnic Health Disparities | 2022 |
Heavy Smoking Patients Receiving a Lung Cancer Screen Want to Quit: A Call for Tailored Cessation Interventions | Frontiers in Medicine | 2022 |
Kliniğimizde İzlenen Akciğer Kanseri Hastalarında Klinik Özellikler ve Sağ Kalımı Etkileyen Faktörlerin Değerlendirilmesi: Zonguldak Bülent Ecevit Üniversitesi Hastanesi Örneği | Medical Journal of Western Black Sea | 2022 |
GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer. | World Journal of Clinical Oncology | 2022 |
The Predictive Value of PD-L1 Expression Level in Evaluating the Cost-Effectiveness of Atezolizumab/Pembrolizumab. | Frontiers in Oncology | 2022 |
Table_7.docx | | 2018 |
Table_6.docx | | 2018 |
Table_5.docx | | 2018 |
Table_4.docx | | 2018 |
Table_3.docx | | 2018 |
Table_2.docx | | 2018 |
Table_1.DOCX | | 2018 |
Image_9.pdf | | 2018 |
Image_8.PDF | | 2018 |
Image_7.PDF | | 2018 |
Image_6.PDF | | 2018 |
Image_5.PDF | | 2018 |
Image_4.PDF | | 2018 |
Image_3.PDF | | 2018 |
Image_2.PDF | | 2018 |
Image_1.PDF | | 2018 |
Data_Sheet_1.DOCX | | 2018 |
Table_1.DOCX | | 2020 |
Image_4.jpeg | | 2019 |
Image_3.jpeg | | 2019 |
Image_2.jpg | | 2019 |
Image_1.JPEG | | 2019 |
Inflammatory Respiratory Diseases: Correlation Between Lung Cancer and COVID-19 | | 2022 |
Real-World Outcomes Among Crizotinib-Treated Patients with ROS1-Positive Advanced Non-Small-Cell Lung Cancer: A Community Oncology-Based Observational Study. | Targeted Oncology | 2021 |
A potential treatment option for advanced non-small cell lung cancer: Three cases. | Explore: the Journal of Science and Healing | 2022 |
18F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules. | PLoS ONE | 2022 |
Perceptions of somatic and affective symptoms and psychosocial care utilization in younger and older survivors of lung cancer. | Supportive Care in Cancer | 2022 |
Spatial assessment of advanced-stage diagnosis and lung cancer mortality in Brazil. | PLoS ONE | 2022 |
Combination of Nutritional Risk Index and Handgrip Strength on the Survival of Patients with Cancer Cachexia: A Multi- Center Cohort Study. | Journal of Inflammation Research | 2022 |
Healthcare Utilization Disparities Among Lung Cancer Patients in US Hospitals During 2010-2014: Evidence from the US Hispanic Population's Hospital Charges and Length of Stay. | International Journal of General Medicine | 2022 |
Thoracoscopic Lobectomy Versus Sublobar Resection for pStage I Geriatric Non-Small Cell Lung Cancer. | Frontiers in Oncology | 2021 |
Real-world treatment patterns in resectable (stages I-III) non-small-cell lung cancer: a systematic literature review. | Future Oncology | 2022 |
Triglyceride-Glucose Index Is Not Associated With Lung Cancer Risk: A Prospective Cohort Study in the UK Biobank | Frontiers in Oncology | 2021 |
Estimating the Financial Impact of Gene Therapy* | | |
Behavioral Risk Factors: A Guide for Oncology Nurses Counseling Patients | Clinical Journal of Oncology Nursing | 2020 |
Lessons for Precision Medicine from Lung Cancer | Respiratory Medicine | 2020 |
Preisbildung von Pharmaprodukten | | 2020 |
Endoscopic restoration of the left lung main bronchi for unresectable metastatic cancer complete obstruction | Endoscopic Surgery | 2020 |
Respiratory support for endoscopic operations on the larynx, trachea, bronchi | Onkologiya Zhurnal Imeni P A Gertsena | 2020 |
Immune checkpoint blockade in the treatment of advanced non-small cell lung cancer - predictors of response and impact of previous radiotherapy | Acta Oncológica | 2021 |
Principles of Cancer Surgery in Older Adults | | 2020 |
Malignant Epithelial Tumors of the Lung | | 2020 |
Flexible Bronchoscopy and the Application of Endobronchial Brachytherapy, Fiducial Placement, Radiofrequency Ablation, and Microwave Ablation | | 2020 |
Factors affecting delay in diagnosis and treatment of lung cancer | Journal of Surgery and Medicine | 2019 |
Stromal Hedgehog pathway activation by IHH suppresses lung adenocarcinoma growth and metastasis by limiting reactive oxygen species | | |
A Model-Based Cost-Effectiveness Analysis of an Exercise Program for Lung Cancer Survivors Following Curative-Intent Treatment | | |
CLINICAL AND CYTOMORPHOLOGICAL EVALUATION OF PRIMARY LUNG NEOPLASMS IN A TERTIARY CARE TEACHING CENTRE OF SOUTH INDIA | Journal of Evolution of Medical and Dental Sciences | 2017 |
Principles of Cancer Surgery in Older Adults | | 2017 |
Gene Signature | | 2017 |
Lung Cancer | | 2016 |
Mass Screening for the Early Detection of Lung Cancer | Japanese Journal of Lung Cancer | 2014 |
Carcinoma/Undifferentiated Tumor | | 2014 |
Molecular Pathology of Lung Cancers | | 2013 |
Power Analysis for the Mean Effect Size | | 2012 |
Racial and Ethnic Diversity in Lung Cancer | | 2010 |
Metastatic BRAF V600E-Mutated Adenocarcinoma of the Lung Presenting as Extreme Neutrophilia and Eosinophilia | Cureus | 2021 |
Results of Second Round Lung Cancer Screening by Low-Dose CT scan - French Cohort Study (DEP-KP80) | Clinical Lung Cancer | 2021 |
Extended parallel process model (EPPM) in evaluating lung Cancer risk perception among older smokers | BMC Public Health | 2021 |
Biopsy frequency and complications among lung cancer patients in the United States | Lung Cancer Management | 2020 |
Prediction of the 1-Year Risk of Incident Lung Cancer: Prospective Study Using Electronic Health Records from the State of Maine | Journal of Medical Internet Research | 2019 |
Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma | Oncotarget | 2015 |
The role of EGFR mutations in predicting recurrence in early and locally advanced lung adenocarcinoma following definitive therapy | Oncotarget | 2020 |
PD-1/PD-L1 antibodies efficacy and safety versus docetaxel monotherapy in advanced NSCLC patients after first-line treatment option: systems assessment | Oncotarget | 2017 |
Isoalantolactone induces intrinsic apoptosis through p53 signaling pathway in human lung squamous carcinoma cells | PLoS ONE | 2017 |
Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting | PLoS ONE | 2017 |
Identification of Gene Expression Differences between Lymphangiogenic and Non-Lymphangiogenic Non-Small Cell Lung Cancer Cell Lines | PLoS ONE | 2016 |
PD-L1 expression correlation with metabolic parameters of FDG PET/CT and clinicopathological characteristics in non-small cell lung cancer | EJNMMI Research | 2020 |
Epidemiology: development and perspectives | | |
CCT6A suppresses SMAD2 and promotes prometastatic TGF-β signaling | Journal of Clinical Investigation | 2017 |
Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypes | JCI Insight | 2016 |
Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer | JCI Insight | 2019 |
The Influence of Social and Economic Conditions on Respiratory Health | Respiratory Medicine | 2017 |
Aromatase Inhibitors Beyond Breast Cancer: Endometrium Versus Breast Puzzle and Other Issues | Resistance To Targeted Anti-cancer Therapeutics | 2015 |
What Are the Numbers? The Epidemiology of Cancer by Sexual Orientation and Gender Identity | | 2015 |